Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration.

Inka PirinenSanna LeinonenMika HelminenPekko HujanenAnu Vaajanen Anja Tuulonen Hannele Uusitalo-Järvinen

Published in: Acta ophthalmologica (2022)

nAMD and glaucoma were found co-existing in the same eye at rates that were similar to the age-corrected prevalence of the two diseases in the general population. Our results suggest that intravitreal anti-VEGF treatment for nAMD may accelerate glaucoma progression.

Keyphrases

age related macular degeneration
vascular endothelial growth factor
endothelial cells
risk factors
optic nerve
diabetic retinopathy
combination therapy
optical coherence tomography
cataract surgery
replacement therapy